All Stories
All Impact Stories
10
Minute Read

Podcast: MSU Research, Education and Clinical Care “Meet the Health Needs of the Entire State”

Written by
Russ White
Published on
April 24, 2024
MSU Today with Russ White

Michigan State University Executive Vice President for Health Sciences Norman J. Beauchamp Jr., M.D., M.H.S. and MSU Vice President for Strategic Initiatives Bill Beekman discuss progress on implementation of the sustainable health theme of the MSU 2030 strategic plan.

Conversation Highlights:

(1:28) – Beauchamp describes his role as executive vice president and what brought him back to his alma mater.

(3:50) – More on the breadth and depth and mission of MSU Health Sciences. “In all we do, whether it’s research, education or our clinical care, we go directly at meeting the health needs of the people of the entire state.”

(8:39) – The opportunities presented by the burgeoning Henry Ford Health + Michigan State University Health Sciences partnership. This includes the recent MSU Board of Trustees approval to build “the largest human health research building in the history of Michigan State University.”

(16:49) – MSU's efforts in Flint, including MSU’s first philanthropically-named department, the Charles Stewart Mott Department of Public Health. “What’s happening in Flint is emblematic of how MSU works with communities.”

(24:10) – Beauchamp reflets on his time and “scalable impact” at MSU and his new role at Georgetown. “What we’ve been able to build is something that will continue to accelerate because of the commitment to hope, health and healing.”  

Listen to “MSU Today with Russ White” on the radio and through Spotify, Apple Podcasts, and wherever your get your shows.

No items found.

No items found.
Russ White
Author Email
Author Email
No items found.
News

MSU Health Sciences News

Get the latest updates on our programs and initiatives.

MSU scientists create first human heart organoid to replicate A-fib

MSU researchers have created the first human heart-like “organoids” that enable the study of atrial fibrillation, or A-fib.

Scientists explore new treatment of drug for rare disorder

MSU and Corewell Health researchers are testing a decades-old drug, DFMO, as a potential treatment for the ultra-rare genetic disorder Bachmann-Bupp syndrome.

Thousands of Detroit families can now benefit from Rx Kids

Enrollment for Rx Kids Detroit is now live at RxKids.org and is open to all city of Detroit families who are at least 16 weeks pregnant or who have a 2026 newborn.